These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1306123)

  • 1. Structural basis of the butyrylcholinesterase H-variant segregating in two Danish families.
    Jensen FS; Bartels CF; La Du BN
    Pharmacogenetics; 1992 Oct; 2(5):234-40. PubMed ID: 1306123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites.
    Bartels CF; Jensen FS; Lockridge O; van der Spek AF; Rubinstein HM; Lubrano T; La Du BN
    Am J Hum Genet; 1992 May; 50(5):1086-103. PubMed ID: 1570838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an unstable variant (BChE115D) of human butyrylcholinesterase.
    Primo-Parmo SL; Lightstone H; La Du BN
    Pharmacogenetics; 1997 Feb; 7(1):27-34. PubMed ID: 9110359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA mutations associated with the human butyrylcholinesterase J-variant.
    Bartels CF; James K; La Du BN
    Am J Hum Genet; 1992 May; 50(5):1104-14. PubMed ID: 1349196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two different point mutations associated with the fluoride-resistant phenotype for human butyrylcholinesterase.
    Nogueira CP; Bartels CF; McGuire MC; Adkins S; Lubrano T; Rubinstein HM; Lightstone H; Van der Spek AF; Lockridge O; La Du BN
    Am J Hum Genet; 1992 Oct; 51(4):821-8. PubMed ID: 1415224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic basis of the silent phenotype of serum butyrylcholinesterase in three compound heterozygotes.
    Maekawa M; Sudo K; Kanno T; Kotani K; Dey DC; Ishikawa J; Izumi M; Etoh K
    Clin Chim Acta; 1995 Feb; 235(1):41-57. PubMed ID: 7634491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrylcholinesterase variants and the new methods of molecular biology.
    La Du BN
    Acta Anaesthesiol Scand; 1995 Feb; 39(2):139-41. PubMed ID: 7793177
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenotypic and molecular biological analysis of human butyrylcholinesterase variants.
    La Du BN; Bartels CF; Nogueira CP; Hajra A; Lightstone H; Van der Spek A; Lockridge O
    Clin Biochem; 1990 Oct; 23(5):423-31. PubMed ID: 2253336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
    Gätke MR; Bundgaard JR; Viby-Mogensen J
    Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population.
    Yen T; Nightingale BN; Burns JC; Sullivan DR; Stewart PM
    Clin Chem; 2003 Aug; 49(8):1297-308. PubMed ID: 12881446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
    Eskildsen KZ; Gätke MR
    Ugeskr Laeger; 2015 Apr; 177(18):866-8. PubMed ID: 26539575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
    Eskildsen KZ; Gätke MR
    Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene.
    Primo-Parmo SL; Bartels CF; Wiersema B; van der Spek AF; Innis JW; La Du BN
    Am J Hum Genet; 1996 Jan; 58(1):52-64. PubMed ID: 8554068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine.
    Lockridge O
    Pharmacol Ther; 1990; 47(1):35-60. PubMed ID: 2195556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid identification of atypical variant of plasma butyrylcholinesterase by PCR.
    Ceppa F; Gidenne S; Benois A; Fontan E; Burnat P
    Clin Chem Lab Med; 2002 Aug; 40(8):799-801. PubMed ID: 12392308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to succinylcholine in patients carrying the K-variant of the butyrylcholinesterase gene.
    Bretlau C; Sørensen MK; Vedersoe AL; Rasmussen LS; Gätke MR
    Anesth Analg; 2013 Mar; 116(3):596-601. PubMed ID: 23400986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase.
    McGuire MC; Nogueira CP; Bartels CF; Lightstone H; Hajra A; Van der Spek AF; Lockridge O; La Du BN
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):953-7. PubMed ID: 2915989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
    Delacour H; Lushchekina S; Mabboux I; Bousquet A; Ceppa F; Schopfer LM; Lockridge O; Masson P
    PLoS One; 2014; 9(7):e101552. PubMed ID: 25054547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prolonged neuromuscular block in a patient with butyrylcholinesterase deficiency].
    Mabboux I; Hary B; Courcelle S; Ceppa F; Delacour H
    Arch Pediatr; 2016 May; 23(5):497-500. PubMed ID: 27017361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian-population study.
    Lando G; Mosca A; Bonora R; Azzario F; Penco S; Marocchi A; Panteghini M; Patrosso MC
    Pharmacogenetics; 2003 May; 13(5):265-70. PubMed ID: 12724618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.